Cytokinetics, Incorporated (NASDAQ:CYTK) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) have been given a consensus rating of “Moderate Buy” by the sixteen analysts that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and fifteen have issued a buy rating on the company. The average 1 […]
More Stories
S&W Seed (NASDAQ:SANW) Now Covered by StockNews.com
Equities research analysts at StockNews.com began coverage on shares of S&W Seed (NASDAQ:SANW – Get Free Report) in a research...
Kontoor Brands (NYSE:KTB) Given New $86.00 Price Target at Barclays
Kontoor Brands (NYSE:KTB – Get Free Report) had its price target upped by equities research analysts at Barclays from $75.00...
Veradigm (NASDAQ:MDRX) Coverage Initiated by Analysts at StockNews.com
Analysts at StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a report released on Tuesday....
Mettler-Toledo International (NYSE:MTD) Stock Rating Upgraded by UBS Group
Mettler-Toledo International (NYSE:MTD – Get Free Report) was upgraded by stock analysts at UBS Group from a “neutral” rating to...
Melius Upgrades Kroger (NYSE:KR) to “Hold”
Kroger (NYSE:KR – Get Free Report) was upgraded by analysts at Melius from a “sell” rating to a “hold” rating...
StockNews.com Begins Coverage on Penns Woods Bancorp (NASDAQ:PWOD)
StockNews.com started coverage on shares of Penns Woods Bancorp (NASDAQ:PWOD – Get Free Report) in a research note issued to...